120 related articles for article (PubMed ID: 9713274)
1. The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy.
Kuczyk MA; Serth J; Bokemeyer C; Machtens S; Minssen A; Bathke W; Hartmann J; Jonas U
Eur J Cancer; 1998 Apr; 34(5):679-86. PubMed ID: 9713274
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
[TBL] [Abstract][Full Text] [Related]
3. p53 overexpression as a prognostic factor for advanced stage bladder cancer.
Kuczyk MA; Bokemeyer C; Serth J; Hervatin C; Oelke M; Höfner K; Tan HK; Jonas U
Eur J Cancer; 1995 Dec; 31A(13-14):2243-7. PubMed ID: 8652250
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
Kuczyk MA; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074
[TBL] [Abstract][Full Text] [Related]
5. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
Int J Cancer; 2001 Sep; 95(5):337-42. PubMed ID: 11494236
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.
Quinn DI; Henshall SM; Head DR; Golovsky D; Wilson JD; Brenner PC; Turner JJ; Delprado W; Finlayson JF; Stricker PD; Grygiel JJ; Sutherland RL
Cancer Res; 2000 Mar; 60(6):1585-94. PubMed ID: 10749127
[TBL] [Abstract][Full Text] [Related]
7. p53 and bcl-2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical prostatectomy.
Oxley JD; Winkler MH; Parry K; Brewster S; Abbott C; Gillatt DA
BJU Int; 2002 Jan; 89(1):27-32. PubMed ID: 11849156
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
11. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
12. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate.
Theodorescu D; Broder SR; Boyd JC; Mills SE; Frierson HF
J Urol; 1997 Jul; 158(1):131-7. PubMed ID: 9186339
[TBL] [Abstract][Full Text] [Related]
13. p53 nuclear accumulation as an early indicator of lethal prostate cancer.
Quinn DI; Stricker PD; Kench JG; Grogan J; Haynes AM; Henshall SM; Grygiel JJ; Delprado W; Turner JJ; Horvath LG; Mahon KL
Br J Cancer; 2019 Oct; 121(7):578-583. PubMed ID: 31409910
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer.
Kuczyk MA; Machtens S; Bokemeyer C; Hradil K; Macheel I; Jetscho V; Hartmann J; Thon WF; Jonas U; Serth J
Oncol Rep; 1999; 6(3):687-93. PubMed ID: 10203616
[TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Kuczyk M; Serth J; Machtens S; Bokemeyer C; Bathke W; Stief C; Jonas U
Br J Urol; 1998 Mar; 81(3):406-12. PubMed ID: 9523661
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy.
Bettencourt MC; Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Moul JW
J Urol; 1996 Sep; 156(3):1064-8. PubMed ID: 8709308
[TBL] [Abstract][Full Text] [Related]
17. p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer.
Schwandner O; Schiedeck TH; Bruch HP; Duchrow M; Windhoevel U; Broll R
Eur J Cancer; 2000 Feb; 36(3):348-56. PubMed ID: 10708936
[TBL] [Abstract][Full Text] [Related]
18. p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.
Bauer JJ; Sesterhenn IA; Mostofi KF; McLeod DG; Srivastava S; Moul JW
Clin Cancer Res; 1995 Nov; 1(11):1295-300. PubMed ID: 9815924
[TBL] [Abstract][Full Text] [Related]
19. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]